Key result
The synergy between engineering-aided biological discovery and biology-inspired engineering solutions will be the path forward for translating laboratory results into clinical practice.
This review highlights the synergy between engineering and biology in understanding skeletal muscle pathology and developing new therapies for muscle disorders.
May accelerate muscle disorder therapies; leaves open prospective validation of engineering-biology synergies.
Although skeletal muscle is one of the most regenerative organs in our body, various genetic defects, alterations in extrinsic signaling, or substantial tissue damage can impair muscle function and the capacity for self-repair. The diversity and complexity of muscle disorders have attracted much interest from both cell biologists and, more recently, bioengineers, leading to concentrated efforts to better understand muscle pathology and develop more efficient therapies. This review describes the biological underpinnings of muscle development, repair, and disease, and discusses recent bioengineering efforts to design and control myomimetic environments, both to study muscle biology and function and to aid in the development of new drug, cell, and gene therapies for muscle disorders. The synergy between engineering-aided biological discovery and biology-inspired engineering solutions will be the path forward for translating laboratory results into clinical practice.
No takes yet. Share an insight, caveat, or question.
Bursac et al. (2015) conducted a review in Skeletal muscle injury and disease. Bioengineering and myomimetic environments was evaluated. The synergy between engineering-aided biological discovery and biology-inspired engineering solutions will be the path forward for translating laboratory results into clinical practice.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: